Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.45 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | ALPI | P09923 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.41 |
| ▸ | XIAP | P98170 | 1/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.41 |
| ▸ | CPA3 | P15088 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1552921 | 0.82 | TRPA1 (0.54) | TRPA1SLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL12708159 | 0.82 | TRPA1 (0.54) | TRPA1SLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL7252952 | 0.81 | EPHX1 (0.55) | TRPA1SLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL6682088 | 0.80 | TDP1 (0.46) | TRPA1SLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL9456004 | 0.80 | TDP1 (0.46) | SLC6A2TAAR1MAOASLC6A4SLC6A3 | |
| Hydrogen Sulfide SCHEMBL9623454 | 0.79 | EPHX1 (0.52) | TRPA1SLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL29828349 | 0.78 | EPHX1 (0.48) | SLC6A2TAAR1MAOASLC6A4SLC6A3 | |
| SCHEMBL8746113 | 0.78 | SIGMAR1 (0.46) | TRPA1SLC6A2TAAR1MAOASLC6A4 | |
| SCHEMBL1114633 | 0.78 | CPA3 (0.62) | SLC6A3CYP1A2TSHRALPIPKM | |
| SCHEMBL9441158 | 0.77 | CYP1A2 (0.52) | TRPA1SLC6A2TAAR1MAOASLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4121438-A2 | NEUROACTIVE STEROIDS AND THEIR METHODS OF USE | Sage Therapeutics, Inc. (US) | 2023-01-25 | — | — | EP | disclosed |
| WO-2021188778-A2 | NEUROACTIVE STEROIDS AND THEIR METHODS OF USE | SAGE THERAPEUTICS, INC. (US) | 2021-09-23 | — | — | WO | disclosed |
| US-20090181948-A1 | DIAMINE DERIVATIVE | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2009-07-16 | — | — | US | disclosed |
| EP-1847530-A1 | DIAMINE DERIVATIVE | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2007-10-24 | — | — | EP | disclosed |
| EP-0863875-B1 | NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY | HOFFMANN LA ROCHE (CH) | 2003-06-04 | — | — | EP | disclosed |
| US-6420574-B1 | — | — | 2002-07-16 | — | — | US | disclosed |
| US-6420574-B2 | REACTING 1-(4-FLUOROPHENYL)-1,3-DIHYDROISOBENZOFURAN-5-CARBONITRILE WITH SUBSTITUTED ALKYL HALIDE/SULFONATE; CHEMICAL INTERMEDIATE CONVERTED TO AMINE; ANTIDEPRESSANT; AVOIDS BY-PRODUCT FORMATION | H. LUNDBECK A/S (DK) | 2002-07-16 | — | — | US | disclosed |
| US-20010027256-A1 | Method for the preparation of citalopram | H. LUNDBECK A/S (DK) | 2001-10-04 | — | — | US | disclosed |
| EP-0863875-A1 | NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY | F. HOFFMANN-LA ROCHE AG (CH) | 1998-09-16 | — | — | EP | disclosed |
| WO-1997009311-A1 | NEW 4-(OXYALKOXYPHENYL)-3-OXY-PIPERIDINES FOR TREATING HEART AND KIDNEY INSUFFICIENCY | F. HOFFMANN-LA ROCHE AG (CH) | 1997-03-13 | — | — | WO | disclosed |
| CN-1076690-A | SULFONAMIDOCARBOXAMIDES | HOFFMANN LA ROCHE (CH) | 1993-09-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090181948-A1 | DIAMINE DERIVATIVE | ARG1, PRMT5, PRMT1 | TRPA1 4666/4885SLC6A2 3400/4885TAAR1 1445/4885 |
| US-20010027256-A1 | Method for the preparation of citalopram | CRHR1, CRHR2, MC3R | TRPA1 4632/4885SLC6A2 157/4885TAAR1 220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.